These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3318451)

  • 1. Structure and biochemical effects of fenofibrate.
    Kloer HU
    Am J Med; 1987 Nov; 83(5B):3-8. PubMed ID: 3318451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The biochemical pharmacology of fenofibrate.
    Caldwell J
    Cardiology; 1989; 76 Suppl 1():33-41; discussion 41-4. PubMed ID: 2713875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma lipid concentrations and lecithin:cholesterol acyltransferase activity in normolipidemic subjects given fenofibrate and colestipol.
    Heller FR; Desager JP; Harvengt C
    Metabolism; 1981 Jan; 30(1):67-71. PubMed ID: 7464555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic fatty acid metabolism as a determinant of plasma and liver triacylglycerol levels. Studies on tetradecylthioacetic and tetradecylthiopropionic acids.
    Asiedu DK; al-Shurbaji A; Rustan AC; Björkhem I; Berglund L; Berge RK
    Eur J Biochem; 1995 Feb; 227(3):715-22. PubMed ID: 7867630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ciprofibrate and fenofibrate on liver lipids and lipoprotein synthesis in normo- and hyperlipidemic rats.
    Petit D; Bonnefis MT; Rey C; Infante R
    Atherosclerosis; 1988 Dec; 74(3):215-25. PubMed ID: 3240333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential use of fenofibrate and other fibric acid derivatives in the clinic.
    Brown WV
    Am J Med; 1987 Nov; 83(5B):85-9. PubMed ID: 3688012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of lipid metabolism and gene expression by fenofibrate in hamsters.
    Guo Q; Wang PR; Milot DP; Ippolito MC; Hernandez M; Burton CA; Wright SD; Chao Y
    Biochim Biophys Acta; 2001 Oct; 1533(3):220-32. PubMed ID: 11731332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for the inhibition of platelet-derived growth factor induced rat smooth muscle cells DNA synthesis by fenofibric acid at the Go/G1 cell cycle level.
    Pascal M; Sepulchre C; Chazan JB; Majoie B
    Life Sci; 1983 Sep; 33(10):925-33. PubMed ID: 6888156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of fenofibrate on plasma lipoproteins in hypercholesterolemia and combined hyperlipidemia.
    Knopp RH; Brown WV; Dujovne CA; Farquhar JW; Feldman EB; Goldberg AC; Grundy SM; Lasser NL; Mellies MJ; Palmer RH
    Am J Med; 1987 Nov; 83(5B):50-9. PubMed ID: 3318454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibric acids: effects on lipids and lipoprotein metabolism.
    Grundy SM; Vega GL
    Am J Med; 1987 Nov; 83(5B):9-20. PubMed ID: 3318457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Free fatty acid metabolism during fenofibrate treatment of the metabolic syndrome.
    Vega GL; Cater NB; Hadizadeh DR; Meguro S; Grundy SM
    Clin Pharmacol Ther; 2003 Sep; 74(3):236-44. PubMed ID: 12966367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in plasma activities of lipolytic enzymes and lipids of normolipidemic subjects given phenobarbital, a strong microsomal inducer, alone or in combination with fenofibrate.
    Heller FR; Desager JP; Harvengt C
    Int J Clin Pharmacol Ther Toxicol; 1988 Mar; 26(3):138-42. PubMed ID: 3410596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of lipoprotein production in Hep G2 cells by fenofibrate and clofibrate.
    Hahn SE; Goldberg DM
    Biochem Pharmacol; 1992 Feb; 43(3):625-33. PubMed ID: 1311585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of fenofibrate and extended-release niacin on high-density lipoprotein particle size distribution and cholesterol efflux capacity in dyslipidemic patients.
    Franceschini G; Favari E; Calabresi L; Simonelli S; Bondioli A; Adorni MP; Zimetti F; Gomaraschi M; Coutant K; Rossomanno S; Niesor EJ; Bernini F; Benghozi R
    J Clin Lipidol; 2013; 7(5):414-22. PubMed ID: 24079282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro formation of HDL-2 from HDL-3 and triacylglycerol-rich lipoproteins by the action of lecithin:cholesterol acyltransferase and cholesterol ester transfer protein.
    Zechner R; Dieplinger H; Steyrer E; Groener J; Calvert D; Kostner GM
    Biochim Biophys Acta; 1987 Mar; 918(1):27-35. PubMed ID: 3828365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of fenofibrate and LF 2151 on hepatic peroxisomes in hamsters.
    Pourbaix S; Heller F; Harvengt C
    Biochem Pharmacol; 1984 Nov; 33(22):3661-6. PubMed ID: 6508822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coordinated alteration of hepatic gene expression in fatty acid and triglyceride synthesis in LCAT-null mice is associated with altered PUFA metabolism.
    Song H; Zhu L; Picardo CM; Maguire G; Leung V; Connelly PW; Ng DS
    Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E17-E25. PubMed ID: 16105858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of simvastatin and fenofibrate on the fatty acid composition of hypercholesterolaemic patients.
    Agheli N; Jacotot B
    Br J Clin Pharmacol; 1991 Oct; 32(4):423-8. PubMed ID: 1958434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of fenofibrate treatment on fatty acid oxidation in liver mitochondria of obese Zucker rats.
    Henninger C; Clouet P; Cao Danh H; Pascal M; Bezard J
    Biochem Pharmacol; 1987 Oct; 36(19):3231-6. PubMed ID: 3663237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of clinical studies of fenofibrate in combination with currently approved lipid-lowering drugs.
    Brown WV
    Cardiology; 1989; 76 Suppl 1():45-51; discussion 52-4. PubMed ID: 2653623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.